Mark Kockx, Member Board of Directors at CellCarta

Mark Kockx

Member Board of Directors at CellCarta | Antwerp Metropolitan Area, Belgium

Profile last verified July 2026
Biotechnology Verified Profile Antwerp Metropolitan Area, Belgium University of Antwerp
Verified

Work Email

***@cellcarta.com

Last verified May 2026

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

+32*****

Belgium • Mobile

Free account · No credit card · 5 profiles/month

ContactOut Insights AI Generated

Mark Kockx holds an MD and PhD from the University of Antwerp and currently serves as a Member of the Board of Directors at the biotechnology firm CellCarta, where he also acts as Chief Medical and Scientific Officer. He is additionally the Co-Founder and CEO of HistoGeneX, leveraging his expertise in precision medicine and biomarker analysis to support global clinical trial operations. His leadership focuses on integrating advanced analytical platforms across immunology, histopathology, and genomics to deliver customized bioanalytical solutions for complex healthcare challenges.

BEST APPROACH TO REACH Mark Kockx

Reach out via work email with a concise proposal highlighting how your solution supports CellCarta’s integrated bioanalytical platforms, specifically referencing his dual executive leadership at CellCarta and HistoGeneX.

Mark Kockx Socials
Mark Kockx Work Experience

Head of Department of Pathology at ZNA in August 1994 - August 2026

Mandate for Fundamental Clinical Research at Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO) in August 1994 - August 2026

Member Board of Directors at CellCarta in August 2019 - Present

See more See less

Chief Medical & Scientific Officer at CellCarta in August 2019 - Present

Co-Founder & CEO of HistoGeneX (now part of CellCarta) at CellCarta in April 2001 - July 2019

Mark Kockx Education

University of Antwerp, MD, August 1981 to August 1994

Mark Kockx Skills
Anatomic Pathology Molecular Pathology Biomarker Development
About Mark Kockx’s Current Company
CellCarta

As a global leader in precision medicine testing services, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials. CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as digital pathology/AI and sample management, logistics and kitting services. At CellCarta we are experts at assessing the immune system, whether in the context of oncology, infectious diseases, or autoimmune diseases. With a proven track record in other therapeutic areas as, such as neurological and metabolic disorders, we handle all human biological specimens and deploy relevant technologies to extract valuable information for research and diagnostic applications. We provide assay development and testing services to support a wide variety of translational research, clinical trials, and diagnostic applications. Reflecting our commitment to quality, our sites hold the appropriate accreditations to support your regulatory requirements, including CAP, CLIA, ISO15189, ISO27001 and ISO13485.

Discover more about CellCarta
Mark Kockx’s Colleagues
Johan Strauven

Johan Strauven

Belgium

VP Finance CellCarta HC/GC

Vice President Finance HC/GC at CellCarta
(March 2024 – Present)

Emran Hamdard

Emran Hamdard

Niel, Flemish Region, Belgium

Business Process Improvement Analyst at CellCarta

Business Process Improvement Analyst at CellCarta
(September 2025 – Present)

Leonids Aleksandrovs

Leonids Aleksandrovs

Aalst, Flemish Region, Belgium

Team Manager Global Data Management, Analytics and Reporting

Team Manager Global Data Management, Analytics and Reporting at CellCarta
(March 2022 – Present)

Kristien Verhoeven

Kristien Verhoeven

Antwerp Metropolitan Area

SVP & Chief Operating Officer Histopathology, Genomics & Logistics services

SVP & Global business unit lead Histopathology, Genomics & logistics at CellCarta
(July 2024 – Present)

Pieterjan Vandam

Pieterjan Vandam

Antwerp Metropolitan Area

MD PhD, Associate Director Data Science & Bioinformatics | Molecular Pathologist at CellCarta

Molecular Pathologist at CellCarta
(March 2018 – Present)

Florian Farcette

Florian Farcette

Greater Lille Metropolitan Area

Director Business Development at Cellcarta

Director of Business Development - Northern Europe & UK at CellCarta
(Dec 2024 – Present)

Search similar profiles
Frequently asked questions about Mark Kockx

What is Mark Kockx email address?

Email Mark Kockx at [email protected] and [email protected]. This email is the most updated Mark Kockx's email found in 2026.

What is Mark Kockx phone number?

Mark Kockx phone number is +32497488092.

How to contact Mark Kockx?

To contact Mark Kockx send an email to [email protected] or [email protected]. If you want to call Mark Kockx try calling on +32497488092. (updated on March 11, 2026)

What company does Mark Kockx work for?

Mark Kockx works for CellCarta.

What is Mark Kockx's role at CellCarta?

Mark Kockx is Member Board of Directors

What industry does Mark Kockx work in?

Mark Kockx works in the Biotechnology industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free